SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-010353
Filing Date
2023-02-10
Accepted
2023-02-10 17:00:17
Documents
12
Period of Report
2023-02-08
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea173153-8k_allarity.htm   iXBRL 8-K 26706
  Complete submission text file 0001213900-23-010353.txt   202899

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE allr-20230208.xsd EX-101.SCH 3272
3 XBRL LABEL FILE allr-20230208_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE allr-20230208_pre.xml EX-101.PRE 22389
6 EXTRACTED XBRL INSTANCE DOCUMENT ea173153-8k_allarity_htm.xml XML 3716
Mailing Address 24 SCHOOL ST., 2ND FLOOR BOSTON MA 02108
Business Address 24 SCHOOL ST., 2ND FLOOR BOSTON MA 02108 401-426-4664
Allarity Therapeutics, Inc. (Filer) CIK: 0001860657 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41160 | Film No.: 23613124
SIC: 2834 Pharmaceutical Preparations